Conor McNamara
Stock Analyst at RBC Capital
(1.17)
# 3,713
Out of 5,012 analysts
137
Total ratings
32.67%
Success rate
-14.35%
Average return
Main Sectors:
Stocks Rated by Conor McNamara
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TECH Bio-Techne | Upgrades: Outperform | $61 → $73 | $60.81 | +20.05% | 11 | Sep 3, 2025 | |
| MRVI Maravai LifeSciences Holdings | Maintains: Outperform | $7 → $5 | $3.32 | +50.60% | 7 | Aug 12, 2025 | |
| NTRA Natera | Maintains: Outperform | $251 → $255 | $170.85 | +49.25% | 2 | Aug 8, 2025 | |
| OABI OmniAb | Maintains: Outperform | $4 → $3 | $1.67 | +79.64% | 4 | Aug 7, 2025 | |
| EXAS Exact Sciences | Maintains: Sector Perform | $54 → $46 | $58.54 | -21.41% | 1 | Aug 7, 2025 | |
| HOLX Hologic | Upgrades: Outperform | $72 → $87 | $67.70 | +28.51% | 12 | Aug 6, 2025 | |
| AVTR Avantor | Maintains: Outperform | $20 → $17 | $13.89 | +22.43% | 9 | Aug 4, 2025 | |
| ILMN Illumina | Maintains: Outperform | $118 → $126 | $98.14 | +28.39% | 16 | Aug 1, 2025 | |
| BIO Bio-Rad Laboratories | Maintains: Outperform | $387 → $409 | $303.61 | +34.71% | 12 | Aug 1, 2025 | |
| BIO.B Bio-Rad Laboratories | Maintains: Outperform | $387 → $409 | $300.55 | +36.08% | 12 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $193 → $204 | $150.00 | +36.00% | 12 | Jul 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $651 → $637 | $543.47 | +17.21% | 14 | Apr 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $250 | $209.75 | +19.19% | 10 | Apr 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $64 → $61 | $27.84 | +119.15% | 11 | Feb 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $8 → $7 | $4.27 | +63.93% | 4 | Aug 7, 2024 |
Bio-Techne
Sep 3, 2025
Upgrades: Outperform
Price Target: $61 → $73
Current: $60.81
Upside: +20.05%
Maravai LifeSciences Holdings
Aug 12, 2025
Maintains: Outperform
Price Target: $7 → $5
Current: $3.32
Upside: +50.60%
Natera
Aug 8, 2025
Maintains: Outperform
Price Target: $251 → $255
Current: $170.85
Upside: +49.25%
OmniAb
Aug 7, 2025
Maintains: Outperform
Price Target: $4 → $3
Current: $1.67
Upside: +79.64%
Exact Sciences
Aug 7, 2025
Maintains: Sector Perform
Price Target: $54 → $46
Current: $58.54
Upside: -21.41%
Hologic
Aug 6, 2025
Upgrades: Outperform
Price Target: $72 → $87
Current: $67.70
Upside: +28.51%
Avantor
Aug 4, 2025
Maintains: Outperform
Price Target: $20 → $17
Current: $13.89
Upside: +22.43%
Illumina
Aug 1, 2025
Maintains: Outperform
Price Target: $118 → $126
Current: $98.14
Upside: +28.39%
Bio-Rad Laboratories
Aug 1, 2025
Maintains: Outperform
Price Target: $387 → $409
Current: $303.61
Upside: +34.71%
Bio-Rad Laboratories
Aug 1, 2025
Maintains: Outperform
Price Target: $387 → $409
Current: $300.55
Upside: +36.08%
Jul 30, 2025
Maintains: Outperform
Price Target: $193 → $204
Current: $150.00
Upside: +36.00%
Apr 24, 2025
Maintains: Outperform
Price Target: $651 → $637
Current: $543.47
Upside: +17.21%
Apr 23, 2025
Reiterates: Outperform
Price Target: $250
Current: $209.75
Upside: +19.19%
Feb 13, 2025
Maintains: Outperform
Price Target: $64 → $61
Current: $27.84
Upside: +119.15%
Aug 7, 2024
Maintains: Outperform
Price Target: $8 → $7
Current: $4.27
Upside: +63.93%